biomarkers for glp-1 agonists The expanding role of receptor agonists: a narrative review of current evidence and future directions Pharmacokinetics of a long-acting GLP-1

Certain strains belonging to Nocardiodes (Ikunaga et al., 2011) Sphingomonas (He et al., 2017), and Devosia (He et al., 2015

Tingling or Numbness: Some users report experiencing tingling or numbness, particularly in the fingers or toes

Many people carry complete deletions of GSTM1 or GSTT1, meaning they make no functional enzyme from that gene

2 To mitigate side effects, these medications are started at a low dose and increased over time

Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumor progression

Similarly, the oral GLP-1 RA will also need to demonstrate their cardiovascular safety in these populations (NCT05803421)